|

Understanding CARdiac Events in Breast Cancer

RECRUITINGSponsored by National University of Ireland, Galway, Ireland
Actively Recruiting
SponsorNational University of Ireland, Galway, Ireland
Started2023-01-14
Est. completion2026-01
Eligibility
Age18 Years – 90 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05921279

Summary

In Ireland, over 3,000 patients are diagnosed with breast cancer annually, and 1 in 9 Irish women will be diagnosed with breast cancer in their lifetime. There is evidence that female breast cancer survivors are more likely to die of cardiovascular disease than their age-matched counterparts. This research is focused on evaluating pathways for identifying, managing, and overcoming side effects of cancer therapies that can negatively impact quality-of-life and overall outcomes for women during and after cancer treatment. The Cardio-oncology research team at GUH plan to capitalize on their expertise in both cancer care and cardiology to develop a care pathway for cancer patients who are at increased risk of developing heart disease.

Eligibility

Age: 18 Years – 90 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Women aged ≥ 18 years
* Ability to read and understand English
* Breast Cancer Stage I- III planned to receive systemic chemotherapy

Exclusion Criteria:

* Patients not for systemic chemotherapy with curative intent
* Patients who are unable to co-operate with the study protocol
* Patients who are unable to give informed consent

Conditions8

Breast CancerCancerCardiomyopathiesCardiotoxicityChemotherapeutic ToxicityHeart DiseaseHeart FailureOncology

Browse More Trials

Cancer trialsHeart Disease trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.